AstraZeneca starts Seroquel Phase III

AstraZeneca (AZN; LSE:AZN) began U.S. placebo-controlled Phase III testing of its Seroquel quetiapine antipsychotic in 178 patients with acute manic episodes of bipolar disorder. The study will examin...